<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>10168288</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmid">37162823</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmc">10168288</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="doi">10.1101/2023.04.10.536286</article-id></all-ids><extracted-table><table-id>T1</table-id><table-label>Table 1.</table-label><table-caption>Number of participants with positive/negative depression based on the KSADS scores, total number of participants, and depression prevalence, for the general group as well as the high-risk group (with parental history of depression).</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="T1"><label>Table 1.</label><caption><p id="P42">Number of participants with positive/negative depression based on the KSADS scores, total number of participants, and depression prevalence, for the general group as well as the high-risk group (with parental history of depression).</p></caption><table frame="box" rules="all"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><tbody><tr><td colspan="5" align="left" valign="bottom" rowspan="1">A) Initial sample: baseline with available KSAD</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1">Depression</td><td align="left" valign="bottom" rowspan="1" colspan="1">No depression</td><td align="left" valign="bottom" rowspan="1" colspan="1">Total</td><td align="left" valign="bottom" rowspan="1" colspan="1">Prevalence (%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">General</td><td align="left" valign="middle" rowspan="1" colspan="1">741</td><td align="left" valign="middle" rowspan="1" colspan="1">10993</td><td align="left" valign="middle" rowspan="1" colspan="1">11734</td><td align="left" valign="middle" rowspan="1" colspan="1">6.31</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">High-risk</td><td align="left" valign="middle" rowspan="1" colspan="1">409</td><td align="left" valign="middle" rowspan="1" colspan="1">3066</td><td align="left" valign="middle" rowspan="1" colspan="1">3475</td><td align="left" valign="middle" rowspan="1" colspan="1">11.77</td></tr><tr><td colspan="5" align="left" valign="bottom" rowspan="1">B) MRI matched sample: depression at two-year follow-up visit</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1">Depression</td><td align="left" valign="bottom" rowspan="1" colspan="1">No depression</td><td align="left" valign="bottom" rowspan="1" colspan="1">Total</td><td align="left" valign="bottom" rowspan="1" colspan="1">Prevalence (%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">General</td><td align="left" valign="middle" rowspan="1" colspan="1">358</td><td align="left" valign="middle" rowspan="1" colspan="1">5959</td><td align="left" valign="middle" rowspan="1" colspan="1">6317</td><td align="left" valign="middle" rowspan="1" colspan="1">5.67</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">High-risk</td><td align="left" valign="middle" rowspan="1" colspan="1">195</td><td align="left" valign="middle" rowspan="1" colspan="1">1659</td><td align="left" valign="middle" rowspan="1" colspan="1">1854</td><td align="left" valign="middle" rowspan="1" colspan="1">10.52</td></tr><tr><td colspan="5" align="left" valign="bottom" rowspan="1">C) Final sample: complete data at two-year follow up</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1">Depression</td><td align="left" valign="bottom" rowspan="1" colspan="1">No depression</td><td align="left" valign="bottom" rowspan="1" colspan="1">Total</td><td align="left" valign="bottom" rowspan="1" colspan="1">Prevalence (%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">General</td><td align="left" valign="middle" rowspan="1" colspan="1">132</td><td align="left" valign="middle" rowspan="1" colspan="1">2526</td><td align="left" valign="middle" rowspan="1" colspan="1">2658</td><td align="left" valign="middle" rowspan="1" colspan="1">4.97</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">High-risk</td><td align="left" valign="middle" rowspan="1" colspan="1">59</td><td align="left" valign="middle" rowspan="1" colspan="1">566</td><td align="left" valign="middle" rowspan="1" colspan="1">625</td><td align="left" valign="middle" rowspan="1" colspan="1">9.44</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p id="P43">A) Available sample at baseline with complete KSADS; B) Baseline sample matched with quality controlled (QC) MRI data; C) Final sample with complete data at baseline and two-year follow-up, no depression at baseline and negative scores in bipolar disorder.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1.<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Number of participants with positive/negative depression based on the KSADS scores, total number of participants, and depression prevalence, for the general group as well as the high-risk group (with parental history of depression).</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="box" rules="all"><colgroup><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/></colgroup><tbody><tr><td colspan="5" align="left" valign="bottom">A) Initial sample: baseline with available KSAD</td></tr><tr><td align="left" valign="top"/><td align="left" valign="bottom">Depression</td><td align="left" valign="bottom">No depression</td><td align="left" valign="bottom">Total</td><td align="left" valign="bottom">Prevalence (%)</td></tr><tr><td align="left" valign="middle">General</td><td align="left" valign="middle">741</td><td align="left" valign="middle">10993</td><td align="left" valign="middle">11734</td><td align="left" valign="middle">6.31</td></tr><tr><td align="left" valign="middle">High-risk</td><td align="left" valign="middle">409</td><td align="left" valign="middle">3066</td><td align="left" valign="middle">3475</td><td align="left" valign="middle">11.77</td></tr><tr><td colspan="5" align="left" valign="bottom">B) MRI matched sample: depression at two-year follow-up visit</td></tr><tr><td align="left" valign="top"/><td align="left" valign="bottom">Depression</td><td align="left" valign="bottom">No depression</td><td align="left" valign="bottom">Total</td><td align="left" valign="bottom">Prevalence (%)</td></tr><tr><td align="left" valign="middle">General</td><td align="left" valign="middle">358</td><td align="left" valign="middle">5959</td><td align="left" valign="middle">6317</td><td align="left" valign="middle">5.67</td></tr><tr><td align="left" valign="middle">High-risk</td><td align="left" valign="middle">195</td><td align="left" valign="middle">1659</td><td align="left" valign="middle">1854</td><td align="left" valign="middle">10.52</td></tr><tr><td colspan="5" align="left" valign="bottom">C) Final sample: complete data at two-year follow up</td></tr><tr><td align="left" valign="top"/><td align="left" valign="bottom">Depression</td><td align="left" valign="bottom">No depression</td><td align="left" valign="bottom">Total</td><td align="left" valign="bottom">Prevalence (%)</td></tr><tr><td align="left" valign="middle">General</td><td align="left" valign="middle">132</td><td align="left" valign="middle">2526</td><td align="left" valign="middle">2658</td><td align="left" valign="middle">4.97</td></tr><tr><td align="left" valign="middle">High-risk</td><td align="left" valign="middle">59</td><td align="left" valign="middle">566</td><td align="left" valign="middle">625</td><td align="left" valign="middle">9.44</td></tr></tbody></table></div>A) Available sample at baseline with complete KSADS; B) Baseline sample matched with quality controlled (QC) MRI data; C) Final sample with complete data at baseline and two-year follow-up, no depression at baseline and negative scores in bipolar disorder.</transformed-table></extracted-table><extracted-table><table-id>T2</table-id><table-label>Table 2.</table-label><table-caption>Prediction scores of depression onset at two-year follow-up for the whole sample and the subsample of the high-risk parental depression group.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="T2"><label>Table 2.</label><caption><p id="P44">Prediction scores of depression onset at two-year follow-up for the whole sample and the subsample of the high-risk parental depression group.</p></caption><table frame="box" rules="all"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><tbody><tr><td colspan="6" align="left" valign="bottom" rowspan="1">Prediction scores of depression onset at the two-year follow-up</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td colspan="2" align="left" valign="bottom" rowspan="1">General sample</td><td colspan="2" align="left" valign="bottom" rowspan="1">High-risk</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Features</td><td align="left" valign="middle" rowspan="1" colspan="1">Selection</td><td align="left" valign="middle" rowspan="1" colspan="1">AUROC</td><td align="left" valign="middle" rowspan="1" colspan="1">TNR|TPR&gt;0.7</td><td align="left" valign="middle" rowspan="1" colspan="1">AUROC</td><td align="left" valign="middle" rowspan="1" colspan="1">TNR|TPR&gt;0.7</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">sMRI</td><td align="left" valign="middle" rowspan="1" colspan="1">PCA</td><td align="left" valign="middle" rowspan="1" colspan="1">0.58 (0.030)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.33 (0.081)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.60 (0.090)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.46 (0.134)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1">AOV</td><td align="left" valign="bottom" rowspan="1" colspan="1">0.59 (0.040)</td><td align="left" valign="bottom" rowspan="1" colspan="1">0.41 (0.079)</td><td align="left" valign="bottom" rowspan="1" colspan="1">0.64 (0.077)</td><td align="left" valign="bottom" rowspan="1" colspan="1">0.43 (0.143)</td></tr><tr><td rowspan="2" align="left" valign="top" colspan="1">DTI</td><td align="left" valign="bottom" rowspan="1" colspan="1">PCA</td><td align="left" valign="bottom" rowspan="1" colspan="1">0.59 (0.027)</td><td align="left" valign="bottom" rowspan="1" colspan="1">0.35 (0.072)</td><td align="left" valign="bottom" rowspan="1" colspan="1">0.62 (0.107)</td><td align="left" valign="bottom" rowspan="1" colspan="1">0.45 (0.162)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">AOV</td><td align="left" valign="bottom" rowspan="1" colspan="1">0.58 (0.037)</td><td align="left" valign="bottom" rowspan="1" colspan="1">0.39 (0.085)</td><td align="left" valign="bottom" rowspan="1" colspan="1">0.66 (0.058)</td><td align="left" valign="bottom" rowspan="1" colspan="1">0.52 (0.098)</td></tr><tr><td rowspan="2" align="left" valign="top" colspan="1">task-fMRI</td><td align="left" valign="bottom" rowspan="1" colspan="1">PCA</td><td align="left" valign="bottom" rowspan="1" colspan="1">0.60 (0.046)</td><td align="left" valign="bottom" rowspan="1" colspan="1">0.41 (0.075)</td><td align="left" valign="bottom" rowspan="1" colspan="1">0.56 (0.115)</td><td align="left" valign="bottom" rowspan="1" colspan="1">0.43 (0.135)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">AOV</td><td align="left" valign="bottom" rowspan="1" colspan="1">0.59 (0.044)</td><td align="left" valign="bottom" rowspan="1" colspan="1">0.41 (0.088)</td><td align="left" valign="bottom" rowspan="1" colspan="1">0.59 (0.075)</td><td align="left" valign="bottom" rowspan="1" colspan="1">0.42 (0.151)</td></tr><tr><td rowspan="2" align="left" valign="top" colspan="1">rest-fMRI</td><td align="left" valign="bottom" rowspan="1" colspan="1">PCA</td><td align="left" valign="bottom" rowspan="1" colspan="1">0.60 (0.049)</td><td align="left" valign="bottom" rowspan="1" colspan="1">0.40 (0.085)</td><td align="left" valign="bottom" rowspan="1" colspan="1">0.63 (0.065)</td><td align="left" valign="bottom" rowspan="1" colspan="1">0.50 (0.102)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">AOV</td><td align="left" valign="middle" rowspan="1" colspan="1">0.62 (0.043)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.44 (0.081)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.72 (0.065)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.60 (0.088)</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p id="P45">Numbers in parentheses represent the 95% confidence interval lower/upper bound. Scores: area under the receiver operating characteristic curve (AUROC), and true negative rate conditioned on true positive rate being over 0.7 (TNR|TPR&gt;0.7).</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2.<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Prediction scores of depression onset at two-year follow-up for the whole sample and the subsample of the high-risk parental depression group.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="box" rules="all"><colgroup><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/><col align="left" valign="middle"/></colgroup><tbody><tr><td colspan="6" align="left" valign="bottom">Prediction scores of depression onset at the two-year follow-up</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td colspan="2" align="left" valign="bottom">General sample</td><td colspan="2" align="left" valign="bottom">High-risk</td></tr><tr><td align="left" valign="middle">Features</td><td align="left" valign="middle">Selection</td><td align="left" valign="middle">AUROC</td><td align="left" valign="middle">TNR|TPR&gt;0.7</td><td align="left" valign="middle">AUROC</td><td align="left" valign="middle">TNR|TPR&gt;0.7</td></tr><tr><td align="left" valign="middle">sMRI</td><td align="left" valign="middle">PCA</td><td align="left" valign="middle">0.58 (0.030)</td><td align="left" valign="middle">0.33 (0.081)</td><td align="left" valign="middle">0.60 (0.090)</td><td align="left" valign="middle">0.46 (0.134)</td></tr><tr><td align="left" valign="top"/><td align="left" valign="bottom">AOV</td><td align="left" valign="bottom">0.59 (0.040)</td><td align="left" valign="bottom">0.41 (0.079)</td><td align="left" valign="bottom">0.64 (0.077)</td><td align="left" valign="bottom">0.43 (0.143)</td></tr><tr><td rowspan="2" align="left" valign="top">DTI</td><td align="left" valign="bottom">PCA</td><td align="left" valign="bottom">0.59 (0.027)</td><td align="left" valign="bottom">0.35 (0.072)</td><td align="left" valign="bottom">0.62 (0.107)</td><td align="left" valign="bottom">0.45 (0.162)</td></tr><tr><td align="left" valign="bottom">AOV</td><td align="left" valign="bottom">0.58 (0.037)</td><td align="left" valign="bottom">0.39 (0.085)</td><td align="left" valign="bottom">0.66 (0.058)</td><td align="left" valign="bottom">0.52 (0.098)</td></tr><tr><td rowspan="2" align="left" valign="top">task-fMRI</td><td align="left" valign="bottom">PCA</td><td align="left" valign="bottom">0.60 (0.046)</td><td align="left" valign="bottom">0.41 (0.075)</td><td align="left" valign="bottom">0.56 (0.115)</td><td align="left" valign="bottom">0.43 (0.135)</td></tr><tr><td align="left" valign="bottom">AOV</td><td align="left" valign="bottom">0.59 (0.044)</td><td align="left" valign="bottom">0.41 (0.088)</td><td align="left" valign="bottom">0.59 (0.075)</td><td align="left" valign="bottom">0.42 (0.151)</td></tr><tr><td rowspan="2" align="left" valign="top">rest-fMRI</td><td align="left" valign="bottom">PCA</td><td align="left" valign="bottom">0.60 (0.049)</td><td align="left" valign="bottom">0.40 (0.085)</td><td align="left" valign="bottom">0.63 (0.065)</td><td align="left" valign="bottom">0.50 (0.102)</td></tr><tr><td align="left" valign="middle">AOV</td><td align="left" valign="middle">0.62 (0.043)</td><td align="left" valign="middle">0.44 (0.081)</td><td align="left" valign="middle">0.72 (0.065)</td><td align="left" valign="middle">0.60 (0.088)</td></tr></tbody></table></div>Numbers in parentheses represent the 95% confidence interval lower/upper bound. Scores: area under the receiver operating characteristic curve (AUROC), and true negative rate conditioned on true positive rate being over 0.7 (TNR|TPR&gt;0.7).</transformed-table></extracted-table></extracted-tables-set>